Table 1: Study Design Type of Included Studies (N=30 Studies).
Study Design | Level of Evidence† |
Number of Eligible Studies | |
---|---|---|---|
Gynecologic | Prostate | ||
Systematic review of RCTs | 1a | - | - |
Large RCT | 1b | - | - |
Large RCT unpublished but reported to an international scientific meeting | 1(g) | 0 | 0 |
Small RCT | 2 | 0 | 0 |
Small RCT unpublished but reported to an international scientific meeting | 2(g) | 0 | 0 |
Systematic review of non-RCTs with contemporaneous controls | 3a.1 | - | 1 |
Non-RCT with contemporaneous controls | 3a | 1 | 5 |
Systematic review of non-RCTs with historical controls | 3b.1 | 1 | - |
Non-RCT with historical controls | 3b | 5 | 12 |
Non-RCT presented at international conference | 3(g) | - | - |
Surveillance (database or register) | 4a | 1 | 4 |
Case series (multisite) | 4b | - | - |
Case series (single site) | 4c | - | - |
Retrospective review, modelling | 4d | - | - |
Case series presented at international conference | 4(g) | - | - |
Expert opinion | 5 | - | - |
Total | 8 | 22 |
RCT refers to randomized controlled trial.